Abstract
If the “late” complications of diabetes are indeed the direct and/or indirect consequences of insulin deficiency, we would anticipate that therapeutic measures which effectively normalize blood glucose levels should reduce the frequency and severity of cardiovascular complications associated with diabetes. Therapeutic measures which substantially reduce blood glucose levels but fall short of achieving euglycemia might also be expected to reduce cardiovascular complications if the relationship between the two is linear, but not necessarily if the relationship is more complex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pirart, J. (1978). Diabetes Care 1, Part I 168, Part II 252.
University Group Diabetes Program, (1978). JAMA 240, 37.
Johnsson, S. (1960). Diabetes 9, 1.
Peterson, C.M., et al. (1977). Ann. Int. Med. 86, 425.
Danowski, T.S. and Sunder, J.H. (1978). Diabetes Care 1, 27.
University Group Diabetes Program (1970). Diabetes 19, (Suppl. 2), 789.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Press, New York
About this chapter
Cite this chapter
Kilo, C., Williamson, J.R., Choi, S.C., Miller, J.P. (1979). Refuting the UGDP Conclusion that Insulin Treatment does not Prevent Vascular Complications in Diabetes. In: Camerini-Davalos, R.A., Hanover, B. (eds) Treatment of EARLY DIABETES. Advances in Experimental Medicine and Biology, vol 119. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9110-8_45
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9110-8_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9112-2
Online ISBN: 978-1-4615-9110-8
eBook Packages: Springer Book Archive